Licensing Agreement – Terms of Use
Online Access
Journal of Commercial Biotechnology. 


Authorized users are permitted online access to those issues for which the subscribing institution or individual holds or held valid subscriptions with thinkBiotech, the publisher. These authorized users may download, save, or print text, or other information solely for private use or research.

Authorized users are employees, faculty, staff and students who are officially affiliated with the subscribing institution, individual users who have the appropriate subscriptions to the  Journal of Commercial Biotechnology, and users who have paid access through the pay-per-view facility. Public access may also be provided from designated terminals within the subscribing institution’s IP range. Authorized users may include persons affiliated with remote sites or campuses of the subscribing institution that are administered from the subscribing institution’s site or campus, but not persons affiliated with remote sites or campuses that have a separate administrative staff.

Regarding distance education, students would need to use their university identification numbers in order to go through the university’s proxy server. Should students not enroll or graduate, they should be removed from having access. At no time should alumni be allowed to access via a proxy server.

The subscribing institution is responsible for notifying and updating its IP address and proxy server details within that IP address in order that its authorized users may have access to the  Journal of Commercial Biotechnology and will use its best endeavors to prevent unauthorized use, including making all reasonable efforts to inform authorized users of these guidelines.

Moreover, consortia and institutions with multiple sites require a multi-site subscription. Multi-sites include organizations located in more than one city or which have multiple locations in the same city administered independently. We offer multi-site custom pricing for such situations.

Licensee may fulfill interlibrary loan requests in accord with Section 108 of the United States Copyright Law (17 USC Sec 108, “Limitations on exclusive rights: Reproduction by libraries and archives”) and clause 3 of the Guidelines for the Proviso of Subsection 108(g)(2) prepared by the National Commission on New Technological Uses of Copyrighted Works.

Authorized users may not alter, recompile, copy, resell, redistribute, publish or re-publish, place at a Web site, systematically download, operate a bureau service or print for fee service for distribution to unauthorized users the journal content or any part thereof without explicit permission of thinkBiotech, the copyright holder.

Unless otherwise specified, thinkBiotech holds all rights, including copyright of the  Journal of Commercial Biotechnology, and maintains these rights under all circumstances. However, should the author select the Open Access Option, all rights revert to the author(s). thinkBiotech reserves the right to withdraw any of the  Journal of Commercial Biotechnology or any part of the journal in order to comply with any legal rule or court order, or if thinkBiotech is at risk of liability from the continued availability of the journal or part of it.

Note: thinkBiotech reserves the right to make changes to the licensing agreement should it need to do so. Subscribers will be notified 30 days prior to the change.